SWOG clinical trial number
SWOG-9062
Evaluation of 96 Hour Infusion 5-FU + Cisplatin + Alpha Interferon in Patients with Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck, Phase II
Closed
Phase
Accrual
100%
Published
Abbreviated Title
Evaluation of 96 Hour Infusion 5-FU + Cisplatin + Alpha Interferon in Patients with Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck, Phase II
Activated
08/01/1991
Closed
10/01/1993
Publication Information Expand/Collapse
1995
Evaluation of 96-hour infusion fluorouracil plus cisplatin in combination with alpha interferon for patients with advanced squamous cell carcinoma of the head and neck. A Southwest Oncology Group study.
1994
Alpha interferon (aIFN) + 5-fluorouracil (5-FU) + cisplatin (CDDP) in advanced squamous cell carcinoma of the head and neck (SCCHN): A Southwest Oncology Group (SWOG) phase II trial.